Maurie Markman

No ORCID on file · 1 paper in corpus
nonrandomized-trial 2003
Gynecologic Oncology ·doi:10.1016/s0090-8258(03)00149-5

OBJECTIVES: To evaluate the activity and toxicity of danazol in advanced, recurrent, or persistent endometrial carcinoma. METHODS: Eligible patients with advanced, recurrent, or persistent endometrial carcinoma not amenable to curative the…